|
2024
|
Invention
|
Isolation of stable regulatory t cells and uses thereof.
The invention relates to isolated popul... |
|
2023
|
Invention
|
Altering rna sequences in non-coding regions for modification of protein expression. This inventi... |
|
2022
|
Invention
|
Factor h potentiating antibodies and uses thereof.
The invention relates to novel isolated, synt... |
|
2021
|
Invention
|
Methods and systems for the detection and removal of pathogens from blood.
The invention relates... |
|
|
Invention
|
Compositions and methods to enhance the immune system. The invention relates to the field of mole... |
|
2019
|
Invention
|
Chimeric notch receptors.
The invention relates to chimeric receptors comprising an intracellula... |
|
|
Invention
|
Chimeric notch receptors. The invention relates to chimeric receptors comprising an intracellular... |
|
|
Invention
|
Factor h potentiating antibodies and uses thereof. The invention relates to novel isolated, synth... |
|
2018
|
Invention
|
Factor h potentiating antibodies and uses thereof.
The invention relates to isolated, synthetic ... |
|
|
Invention
|
Method for detecting cd4+cd25+glycoprotein a33(gpa33)high and/or cd4+cd127-gpa33high t cells. hig... |
|
|
Invention
|
Isolation of stable regulatory t cells and uses thereof. The invention relates to isolated popula... |
|
2017
|
Invention
|
Cyclodextrins as procoagulants. The invention relates to substituted cyclodextrins comprising at ... |
|
|
Invention
|
Detection of zika virus nucleic acid.
The disclosure describes methods, kits, apparatus and olig... |
|
|
Invention
|
Detection of zika virus nucleic acid. The invention relates to methods, kits, apparatus and oligo... |
|
2016
|
Invention
|
Methods and systems for the detection and removal of pathogens from blood. The invention relates ... |
|
2015
|
Invention
|
Factor h potentiating antibodies and uses thereof. The invention relates to isolated, synthetic o... |
|
|
Invention
|
Cleavage and exchange of major histocompatibility complex ligands employing azobenzene-containing... |
|
|
Invention
|
Means and methods for breaking noncovalent binding interactions between molecules. Described are ... |
|
2013
|
Invention
|
Methods and means for detecting cells using surface plasmon resonance.
The invention relates to ... |
|
|
Invention
|
Methods and means for detecting cells using surface plasmon resonance. The invention relates to m... |
|
|
Invention
|
Means and methods for investigating nucleic acid sequences.
The invention provides improved meth... |
|
2012
|
Invention
|
Means and methods to determine a risk of multiple organ failure. The invention relates to means a... |
|
2011
|
Invention
|
Immune restricted peptides with increased efficacy.
Immune-restricted peptides, especially HLA-A... |
|
|
Invention
|
Immune restricted peptides with increased efficacy. The present invention relates to immune restr... |
|
|
G/S
|
Pharmaceutical products, blood, blood products and blood
intermediary products all for medical u... |
|
|
Invention
|
Diagnostic methods involving determining gene copy numbers and snps in the fcγrii/fcγriii gene cl... |
|
2010
|
Invention
|
Methods and means for counteracting an activity of an fc domain. The invention provides methods a... |
|
2009
|
Invention
|
Means and methods for investigating nucleic acid sequences. The invention provides improved metho... |
|
|
Invention
|
Means and methods for investigating nucleic acid sequences. The invention provides improved... |
|
|
Invention
|
Factor viii polypeptide having factor viii:c activity. Factor VIII polypeptides having FVIII:C ac... |
|
2008
|
Invention
|
Detecting antigen responsive cells in a sample. The present invention relates to methods for dete... |
|
|
Invention
|
Detecting antigen responsive cells in a sample. The present invention relates to methods f... |
|
|
Invention
|
Methods for increasing the therapeutic efficacy of immunoglobulin g class 3 (igg3) antibodies. H3... |
|
|
Invention
|
Method and kits for detecting antibodies against therapeutic antibodies.
The invention relates t... |
